Trials / Completed
CompletedNCT04437862
A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
A Prospective, Multi-Center, Single Arm Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke: The EvaQ Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- MIVI Neuroscience, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assess the safety and efficacy of the Q Revascularization System to remove thrombi and emboli from the neurovasculature in patients experiencing an acute ischemic stroke
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Q Revascularization System | Q Revascularization System for mechanical thrombectomy |
Timeline
- Start date
- 2020-10-27
- Primary completion
- 2023-04-21
- Completion
- 2023-08-02
- First posted
- 2020-06-18
- Last updated
- 2024-08-09
Locations
8 sites across 2 countries: United States, France
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04437862. Inclusion in this directory is not an endorsement.